191 related articles for article (PubMed ID: 18621744)
1. Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice.
Nyalendo C; Beaulieu E; Sartelet H; Michaud M; Fontaine N; Gingras D; Béliveau R
Carcinogenesis; 2008 Aug; 29(8):1655-64. PubMed ID: 18621744
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice.
Nyalendo C; Sartelet H; Gingras D; Béliveau R
Anticancer Res; 2010 Jun; 30(6):1887-95. PubMed ID: 20651331
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions.
Takino T; Saeki H; Miyamori H; Kudo T; Sato H
Cancer Res; 2007 Dec; 67(24):11621-9. PubMed ID: 18089791
[TBL] [Abstract][Full Text] [Related]
4. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.
Taniwaki K; Fukamachi H; Komori K; Ohtake Y; Nonaka T; Sakamoto T; Shiomi T; Okada Y; Itoh T; Itohara S; Seiki M; Yana I
Cancer Res; 2007 May; 67(9):4311-9. PubMed ID: 17483344
[TBL] [Abstract][Full Text] [Related]
5. Increased aggressiveness of human prostate PC-3 tumor cells expressing cell surface localized membrane type-1 matrix metalloproteinase (MT1-MMP).
Wang X; Wilson MJ; Slaton JW; Sinha AA; Ewing SL; Pei D
J Androl; 2009; 30(3):259-74. PubMed ID: 19136391
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion.
Shamamian P; Pocock BJ; Schwartz JD; Monea S; Chuang N; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 2000 Feb; 127(2):142-7. PubMed ID: 10686978
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.
Koshikawa N; Mizushima H; Minegishi T; Eguchi F; Yotsumoto F; Nabeshima K; Miyamoto S; Mekada E; Seiki M
Cancer Sci; 2011 Jan; 102(1):111-6. PubMed ID: 20946474
[TBL] [Abstract][Full Text] [Related]
8. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
9. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
10. Polarized MT1-MMP-CD44 interaction and CD44 cleavage during cell retraction reveal an essential role for MT1-MMP in CD44-mediated invasion.
Marrero-Diaz R; Bravo-Cordero JJ; Megías D; García MA; Bartolomé RA; Teixido J; Montoya MC
Cell Motil Cytoskeleton; 2009 Jan; 66(1):48-61. PubMed ID: 19023892
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
12. The role of MT2-MMP in cancer progression.
Ito E; Yana I; Fujita C; Irifune A; Takeda M; Madachi A; Mori S; Hamada Y; Kawaguchi N; Matsuura N
Biochem Biophys Res Commun; 2010 Mar; 393(2):222-7. PubMed ID: 20117087
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D
Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876
[TBL] [Abstract][Full Text] [Related]
14. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
Szabova L; Chrysovergis K; Yamada SS; Holmbeck K
Oncogene; 2008 May; 27(23):3274-81. PubMed ID: 18071307
[TBL] [Abstract][Full Text] [Related]
15. Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes.
Hakulinen J; Sankkila L; Sugiyama N; Lehti K; Keski-Oja J
J Cell Biochem; 2008 Dec; 105(5):1211-8. PubMed ID: 18802920
[TBL] [Abstract][Full Text] [Related]
16. Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation.
Langlois S; Nyalendo C; Di Tomasso G; Labrecque L; Roghi C; Murphy G; Gingras D; Béliveau R
Mol Cancer Res; 2007 Jun; 5(6):569-83. PubMed ID: 17541067
[TBL] [Abstract][Full Text] [Related]
17. Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells.
Golubkov VS; Chekanov AV; Savinov AY; Rozanov DV; Golubkova NV; Strongin AY
Cancer Res; 2006 Nov; 66(21):10460-5. PubMed ID: 17079467
[TBL] [Abstract][Full Text] [Related]
18. Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface.
Remacle A; Murphy G; Roghi C
J Cell Sci; 2003 Oct; 116(Pt 19):3905-16. PubMed ID: 12915589
[TBL] [Abstract][Full Text] [Related]
19. Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in Furin-Negative Colon Carcinoma LoVo Cells.
Deryugina EI; Ratnikov BI; Yu Q; Baciu PC; Rozanov DV; Strongin AY
Traffic; 2004 Aug; 5(8):627-41. PubMed ID: 15260832
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells.
Zhao T; Harada H; Teramura Y; Tanaka S; Itasaka S; Morinibu A; Shinomiya K; Zhu Y; Hanaoka H; Iwata H; Saji H; Hiraoka M
J Control Release; 2010 May; 144(1):109-14. PubMed ID: 20096316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
